Novanta Inc (1GSN) - Total Liabilities

Latest as of September 2025: €704.34 Million EUR ≈ $823.44 Million USD

Based on the latest financial reports, Novanta Inc (1GSN) has total liabilities worth €704.34 Million EUR (≈ $823.44 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore Novanta Inc (1GSN) net asset momentum to track the company's year-over-year net asset growth rate.

Novanta Inc - Total Liabilities Trend (2015–2024)

This chart illustrates how Novanta Inc's total liabilities have evolved over time, based on quarterly financial data. See 1GSN free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.

Novanta Inc Competitors by Total Liabilities

The table below lists competitors of Novanta Inc ranked by their total liabilities.

Company	Country	Total Liabilities
Tauron Polska Energia S.A. WAR:TPE	Poland	zł26.20 Billion
Suven Pharmaceuticals Limited NSE:SUVENPHAR	India	Rs11.91 Billion
Asia Commercial Bank VN:ACB	Vietnam	₫931.33 Trillion
Atmus Filtration Technologies Inc. NYSE:ATMU	USA	$1.44 Billion
Andon Health Co Ltd SHE:002432	China	CN¥8.08 Billion
Union Bank of Taiwan Pref TW:2838A	Taiwan	NT$970.36 Billion
Clear Secure Inc NYSE:YOU	USA	$959.75 Million
SiteOne Landscape Supply Inc NYSE:SITE	USA	$1.81 Billion

Liability Composition Analysis (2015–2024)

This chart breaks down Novanta Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Novanta Inc stock valuation.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	2.51	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.88	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.47	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Novanta Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Novanta Inc (2015–2024)

The table below shows the annual total liabilities of Novanta Inc from 2015 to 2024.

Year	Total Liabilities	Change
2024-12-31	€642.81 Million ≈ $751.52 Million	+16.33%
2023-12-31	€552.60 Million ≈ $646.04 Million	-16.73%
2022-12-31	€663.63 Million ≈ $775.85 Million	-6.08%
2021-12-31	€706.59 Million ≈ $826.08 Million	+81.94%
2020-12-31	€388.37 Million ≈ $454.05 Million	-14.18%
2019-12-31	€452.56 Million ≈ $529.09 Million	+28.82%
2018-12-31	€351.32 Million ≈ $410.73 Million	-15.38%
2017-12-31	€415.16 Million ≈ $485.36 Million	+148.94%
2016-12-31	€166.77 Million ≈ $194.97 Million	-2.67%
2015-12-31	€171.34 Million ≈ $200.32 Million	--

About Novanta Inc

F:1GSN Germany Scientific & Technical Instruments

Market Cap

$5.19 Billion

€4.44 Billion EUR

Market Cap Rank

#3852 Global

#702 in Germany

Share Price

€124.00

Change (1 day)

+2.48%

52-Week Range

€84.50 - €145.00

All Time High

€171.00